Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Loncastuximab in high-risk and heavily pretreated relapsed / refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers.

Autor: Zelikson V; University of Virginia Health System, Charlottesville., Gurumurthi A; MD Anderson Cancer Center, Houston, USA; Memorial Sloan Kettering Cancer Center, New York., Sawalha Y; The Ohio State University Comprehensive Cancer Center, Columbus., Annunzio K; The Ohio State University Comprehensive Cancer Center, Columbus., Saha A; Moffit Cancer Center, Tampa., Dong N; Moffit Cancer Center, Tampa., Qualls D; Dana-Farber Cancer Institute, Boston., Amoozgar B; Siteman Cancer Center, Washington University of St Louis, St. Louis., Kahl B; Siteman Cancer Center, Washington University of St Louis, St. Louis., Baird J; City of Hope Cancer Center, Los Angeles., Challa P; Yale University, Yale Cancer Center, New Haven., Huntington SF; Yale University, Yale Cancer Center, New Haven., Santos J; University of Colorado Cancer Center, Anschutz Medical Campus, Denver., Bair S; University of Colorado Cancer Center, Anschutz Medical Campus, Denver., Narkhede M; University of Alabama, Birmingham., Li S; Fox Chase Cancer Center, Philadelphia., Frosch Z; Fox Chase Cancer Center, Philadelphia., Ho C; Fred Hutchinson Cancer Center, Seattle., Smith SD; Fred Hutchinson Cancer Center, Seattle., Winter A; Cleveland Clinic Cancer Center, Cleveland., Landsburg D; Abramson Cancer Center, University of Pennsylvania, Philadelphia., Furqan F; Medical College of Wisconsin, Milwaukee., Hamadani M; Medical College of Wisconsin, Milwaukee., Baird K; Winship Cancer Institute, Emory University, Atlanta., Romancik J; Winship Cancer Institute, Emory University, Atlanta., Alharthy H; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore., Law J; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore., Bojanini L; Stanford Cancer Institute, Stanford., Advani R; Stanford Cancer Institute, Stanford., Hu B; Hunstman Cancer Institute, University of Utah, Salt Lake City., Johnson PC; Mass General Cancer Care, Massachusetts General Hospital, Boston., Grover NS; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill., Merril M; Dana-Farber Cancer Institute, Boston., Crombie JL; Dana-Farber Cancer Institute, Boston., Shafagati N; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore., Sterling C; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore., Nastoupil LJ; MD Anderson Cancer Center, Houston., Epperla N; The Ohio State University Comprehensive Cancer Center, Columbus., Ayers EC; University of Virginia Health System, Charlottesville. Eca2t@uvahealth.org.

Publikováno v: Haematologica [Haematologica] 2024 Nov 14, pp. 0. Date of Electronic Publication: 2024 Nov 14.